This is the mechanism by which cancer tissues limit the host immune response via up-regulation of the abovementioned PD-L1 and its binding to the programmed death-1 (PD-1) receptor on antigen-specific CD8+ T cells (termed adaptive immune resistance) [56,57]. Here, CD274 is linked to cancer.